PTC Therapeutics Archives -

Scotland opens door to Translarna for Duchenne muscular dystrophy

https://pharmaphorum.com/news/scotland-opens-door-to-translarna-for-duchenne-muscular-dystrophy/

Sarepta goes up, PTC goes down – DMD research sways the market

https://pharmaphorum.com/news/dmd-therapy-research-sways-market/

PTC shares soar after SMA drug data impresses market

https://pharmaphorum.com/news/ptc-therapeutics-posts-solid-sma-data/

Pharma collaborates to improve chances of NICE backing Duchenne drugs

https://pharmaphorum.com/news/pharmas-join-improve-duchenne-muscular-dystrophy/

PTC Therapeutics fails to convince FDA panel about DMD drug

https://pharmaphorum.com/news/ptc-therapeutics-fails-convince-fda-panel-dmd-drug/

FDA reviewers slam PTC’s Duchenne drug ahead of meeting

https://pharmaphorum.com/news/fda-reviewers-slam-ptc-dmd-drug-ahead-key-meeting/

Sarepta announces Allergan veteran as next CEO

https://pharmaphorum.com/news/sarepta-announces-doug-ingram-new-ceo/

Outrage over Duchenne drug price reinflamed by PTC’s $35,000 price tag

https://pharmaphorum.com/news/dmd-families-will-still-pay-huge-premium-old-drug-says-ptc/

Marathon sells Duchenne drug to PTC

https://pharmaphorum.com/transversal-categories/rare-diseases/marathon-sells-duchenne-drug-ptc/

Search